日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction for Underwood et al., "Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study"

对 Underwood 等人的论文“DAWNING 研究中接受多替拉韦联合两种核苷类逆转录酶抑制剂治疗的既往接受过抗逆转录病毒治疗但未接受过整合酶抑制剂治疗的 HIV-1 感染成人患者的整合酶抑制剂耐药机制和结构特征”的更正

Underwood, Mark; Horton, Joe; Nangle, Keith; Hopking, Judy; Smith, Kimberly; Aboud, Michael; Wynne, Brian; Sievers, Jörg; Stewart, Eugene L; Wang, Ruolan

Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study

DAWNING 研究中,接受多替拉韦联合两种核苷类逆转录酶抑制剂治疗的既往接受过抗逆转录病毒治疗但未接受过整合酶抑制剂治疗的 HIV-1 感染成人患者的整合酶抑制剂耐药机制和结构特征

Underwood, Mark; Horton, Joe; Nangle, Keith; Hopking, Judy; Smith, Kimberly; Aboud, Michael; Wynne, Brian; Sievers, Jörg; Stewart, Eugene L; Wang, Ruolan

Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study Participants

健康日本受试者单次口服阿巴卡韦/多替拉韦/拉米夫定复方片剂的药代动力学、安全性和耐受性研究

Singh, Rajendra P; Adkison, Kimberly; Wolstenholme, Allen; Hopking, Judy; Wynne, Brian

Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials

阿巴卡韦的使用与心肌梗死和心血管事件风险:临床试验数据的汇总分析

Nan, Cassandra; Shaefer, Mark; Urbaityte, Rimgaile; Oyee, James; Hopking, Judy; Ragone, Leigh; Perger, Teodora; Win, Beta; Vangerow, Harald; McCoig, Cynthia; Vannappagari, Vani